Filing Details
- Accession Number:
- 0001144204-19-000502
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-01-03 19:04:00
- Reporting Period:
- 2019-01-01
- Accepted Time:
- 2019-01-03 19:04:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1270073 | Intercept Pharmaceuticals Inc. | ICPT | Pharmaceutical Preparations (2834) | 223868459 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1559570 | David Shapiro | C/O Intercept Pharmaceuticals, Inc. 10 Hudson Yards, Floor 37 New York NY 10001 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-01-01 | 736 | $100.79 | 38,416 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2019-01-02 | 2,000 | $31.90 | 40,416 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-01-02 | 2,000 | $98.28 | 38,416 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-01-03 | 699 | $97.45 | 37,717 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option to Purchase Common Stock | Disposition | 2019-01-02 | 2,000 | $0.00 | 2,000 | $31.90 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 17,031 | 2023-05-07 | No | 4 | M | Direct |
Footnotes
- Represents shares of common stock withheld to satisfy taxes associated with the vesting of restricted stock and restricted stock units.
- This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.
- This option is fully vested and exercisable.
Billionaire Hedge Funds
